Overland Park, KSNCT04640142Now EnrollingIRB Ready

Primary Immunodeficiency Diseases Clinical Trial in Overland Park, KS

Access cutting-edge primary immunodeficiency diseases treatment through this clinical trial at a research site in Overland Park. Study-provided care at no cost to qualified participants.

Sponsored by Octapharma

Quick Self-Assessment

See if you qualify for this Overland Park location

Preparing your pre-screening questions...

Expert Care in Overland Park

Access primary immunodeficiency diseases specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary immunodeficiency diseases treatment provided free

Apply for This Overland Park Location

Check if you qualify for this primary immunodeficiency diseases clinical trial in Overland Park, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Overland Park

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Overland Park site if eligible
  4. 4Begin participation

About This Primary Immunodeficiency Diseases Study in Overland Park

Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcutaneous human immunoglobulin (Newnorm) in patients with primary immunodeficiency diseases

Sponsor: Octapharma

Who Can Participate

Inclusion Criteria

Age of ≥2 years and ≤75 years 2. Documented and confirmed diagnosis of PID as defined by European Society of Immunodeficiencies (ESID) and the Pan American Group for Immune Deficiency (PAGID) and requiring immunoglobulin replacement therapy due to hypogammaglobulinaemia or agammaglobulinaemia. The exact type of PID must be recorded. 3. At least 12 weeks of regular treatment before the screening visit (i.e., with a stable dosing interval) with any IVIG, SCIG, or fSCIG, with a stable IgG dose between 200 and 800 mg/kg/month. A stable dose is defined as one that deviates less than ±25% from the mean dose for all infusions within this 12-week period before screening. 4. Trough level of IgG ≥5 g/L at screening and documentation of an IgG trough level of ≥5 g/L at least once within the previous 12 weeks. 5. Freely given written informed consent from adult patients or freely given written informed consent from the patient's parent(s)/legal guardian(s) and written infor

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Overland Park?

Yes, this clinical trial (NCT04640142) has an active research site in Overland Park, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Immunodeficiency Diseases Treatment Options in Overland Park, KS

If you're searching for primary immunodeficiency diseases treatment options in Overland Park, KS, this clinical trial (NCT04640142) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Overland Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary immunodeficiency diseases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary immunodeficiency diseases clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Overland Park, KS

See all multiple myeloma clinical trials recruiting in Overland Park — not just this study.

Browse Multiple Myeloma Trials in Overland Park →

Browse More Trials by Condition

Multiple Myeloma TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Overland Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Overland Park, KS